Infantile neuronal ceroid lipofuscinosis: follow-up on a Spanish series
- PMID: 22387303
- DOI: 10.1016/j.gene.2012.02.013
Infantile neuronal ceroid lipofuscinosis: follow-up on a Spanish series
Abstract
Infantile neuronal ceroid lipofuscinosis (INCL; NCL1, Haltia-Santavuori disease) is caused by mutations in the CLN1/PPT gene which are associated with an early onset INCL phenotype. The most detailed descriptions of INCL have come from Finland and a few series have been reported from southern European countries. Clinical course and follow-up of six Spanish patients with INCL are reported with the aim of assessing the chronological evolution and severity of this disease. The age at disease onset ranged from 8 to 15 months. Delayed motor skills were the initial symptom when the disease began before 12 months of age, and ataxia was the first sign when the disease began later. Cognitive decline, which is described between 12 and 18 months of age, occurred from 16 to 20 months of age. In our series early stage is characterized by motor impairment, cognitive decline and autistic features. Visual failure may appear simultaneously with the neurological symptoms, leading quickly to blindness. As reported, psychomotor regression appeared between 2 and 3 years of age. Myoclonic jerks occurred after 24 months of age and epilepsy was the last symptom of the disease. We report two novel mutations in a patient without epilepsy to date and describe the features of two siblings homozygous for the V181M (c.541G>A) mutation, associated with the most severe INCL phenotype. The clinical evolution might be helpful to identify patients affected by this rare disease. Early diagnosis is essential in order to provide genetic counselling to affected families. Our series may contribute to the study of the genotype-phenotype INCL correlation in the Mediterranean countries.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Detection of eight novel palmitoyl protein thioesterase (PPT) mutations underlying infantile neuronal ceroid lipofuscinosis (INCL;CLN1).Hum Mutat. 2000;15(3):273-9. doi: 10.1002/(SICI)1098-1004(200003)15:33.0.CO;2-L. Hum Mutat. 2000. PMID: 10679943
-
Late infantile neuronal ceroid lipofuscinosis: mutations in the CLN2 gene and clinical course in Spanish patients.J Child Neurol. 2013 Apr;28(4):470-8. doi: 10.1177/0883073812448459. Epub 2012 Jul 25. J Child Neurol. 2013. PMID: 22832778
-
Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.Pediatr Neurol. 2009 Oct;41(4):297-300. doi: 10.1016/j.pediatrneurol.2009.04.022. Pediatr Neurol. 2009. PMID: 19748052
-
Early infantile form of neuronal ceroid lipofuscinosis. Four Dutch cases and review of the literature.Clin Neurol Neurosurg. 1987;89(3):161-7. doi: 10.1016/s0303-8467(87)80049-5. Clin Neurol Neurosurg. 1987. PMID: 3311523 Review.
-
Juvenile neuronal ceroid lipofuscinosis and education.Biochim Biophys Acta. 2013 Nov;1832(11):1894-905. doi: 10.1016/j.bbadis.2013.02.017. Epub 2013 Mar 5. Biochim Biophys Acta. 2013. PMID: 23470553 Review.
Cited by
-
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.Cancer Discov. 2019 Feb;9(2):220-229. doi: 10.1158/2159-8290.CD-18-0706. Epub 2018 Nov 15. Cancer Discov. 2019. PMID: 30442709 Free PMC article.
-
Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.Dev Med Child Neurol. 2015 Apr;57(4):366-71. doi: 10.1111/dmcn.12634. Epub 2014 Nov 11. Dev Med Child Neurol. 2015. PMID: 25387857 Free PMC article.
-
Overview of advances in educational and social supports for young persons with NCL disorders.Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165480. doi: 10.1016/j.bbadis.2019.05.016. Epub 2019 May 30. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31152869 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials